Ling Zhang

机构：Continental (United States) · ORCID：0000-0002-8049-6231

发表论文 40 篇 · 总被引 845 次 · h-index 14

代表论文

• FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer (2017 · Cancer Letters · 被引 105)
• Augmenter of liver regeneration protects the kidney from ischaemia‐reperfusion injury in ferroptosis (2019 · Journal of Cellular and Molecular Medicine · 被引 75)
• Qingda granule alleviates cerebral ischemia/reperfusion injury by inhibiting TLR4/NF-κB/NLRP3 signaling in microglia (2024 · Journal of Ethnopharmacology · 被引 55)
• Targets of tumor microenvironment for potential drug development (2024 · MedComm – Oncology · 被引 53)
• Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma (2020 · Cell Death and Disease · 被引 50)
• Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling (2016 · Oncology Letters · 被引 39)